SUMO wrestling with Drp1 at mitochondria.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed.

1. Post-translational modifications of mitochondrion-related proteins: integrative orchestrators of cell fate networks in cardiovascular disease.Cell communication and signaling : CCS · 2026
   Review
2. DRP1, fission and apoptosis.Cell death discovery · 2025
   Review
3. Shaping cardiac destiny: the role of post-translational modifications on endoplasmic reticulum - mitochondria crosstalk in cardiac remodeling.Frontiers in pharmacology · 2024
   Review
4. DRP1: At the Crossroads of Dysregulated Mitochondrial Dynamics and Altered Cell Signaling in Cancer Cells.ACS omega · 2023
   Review
5. SENP3-mediated deSUMOylation of c-Jun facilitates microglia-induced neuroinflammation after cerebral ischemia and reperfusion injury.iScience · 2023
   Article
6. Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors.Frontiers in cardiovascular medicine · 2023
   Review
7. The role of Mitochondrial Fission Proteins in Mitochondrial Dynamics in Kidney Disease.International journal of molecular sciences · 2022
   Review
8. SUMOylation targeting mitophagy in cardiovascular diseases.Journal of molecular medicine (Berlin, Germany) · 2022
   Review
9. SENP3 loss promotes M2 macrophage polarization and breast cancer progression.Molecular oncology · 2022
   Article
10. Acetylation in Mitochondria Dynamics and Neurodegeneration.Cells · 2021
    Review
11. SUMO-specific Isopeptidases Tuning Cardiac SUMOylation in Health and Disease.Frontiers in molecular biosciences · 2021
    Review
12. SUMOylation as a Therapeutic Target for Myocardial Infarction.Frontiers in cardiovascular medicine · 2021
    Review
13. SUMO promotes longevity and maintains mitochondrial homeostasis during ageing in Caenorhabditis elegans.Scientific reports · 2020
    Article
14. The SUMO-specific isopeptidase SENP2 is targeted to intracellular membranes via a predicted N-terminal amphipathic α-helix.Molecular biology of the cell · 2018
    Article
15. Significance of Mitochondrial Protein Post-translational Modifications in Pathophysiology of Brain Injury.Translational stroke research · 2018
    Review
16. A Non-apoptotic Function of MCL-1 in Promoting Pluripotency and Modulating Mitochondrial Dynamics in Stem Cells.Stem cell reports · 2018
    Article
17. Relationship Between β-Amyloid and Mitochondrial Dynamics.Cellular and molecular neurobiology · 2017
    Review
18. SENP3-mediated deSUMOylation of Drp1 facilitates interaction with Mff to promote cell death.Scientific reports · 2017
    Article
19. Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.Biochimica et biophysica acta · 2016
    Review
20. KIF1Bβ and Neuroblastoma: Failure to Divide and Cull.Developmental cell · 2016
    Article

Corrections and comments

• Comment on
  SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia.2013

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as